asthma management Flashcards

1
Q

diagnosis of asthma on examination

A

expiatory wheeze
there may be no abnormality on examination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what would you not expect to see on examination for asthma

A

crackles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what does asthma look like on spirometry

A

obstructive pattern
FEV1/FVC is below the lower limit (usually below 70% but less in older people)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

two key features of asthma

A

obstruction and reversibility (improved with bronchodilator)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

technique of spirometry

A

seated, good seal, good effort, all the way out, no coughing
normal spirometry doesn’t exclude asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

if there is obstruction but no reversibility

A

you might have COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

good control of asthma

A

all of:
daytime symptoms <2 days per week
need for reliever <2 days per week (not including SABA prophylactically before exercise)
no limitation of activities
no symptoms during night or waking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

partial control of asthma

A

one or two of:
daytime symptoms >2 days per week
need for reliever >2 days per week (not including SABA prophylactically before exercise)
any limitation of activity
any symptoms during night or waking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

poor control of asthma

A

three or more of:
daytime symptoms >2 days per week
need for reliever >2 days per week (not including SABA prophylactically before exercise)
any limitation of activity
any symptoms during night or waking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

receivers

A

usually this means short acting beta agonists (SABA): salbutamol, terbutaline (largely interchangeable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

preventers

A

inhaled corticosteroids (ICS)
beclomethasone, budesonide, fluticasone, ciclesonide
also for kids: oral montelukast (LTRA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

symptom controllers

A

long acting beta agonists LABA
formoterol (faster), salmeterol (slower), vilanterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

formoterol might be used

A

might be used as a releiver as well because its fast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ICS/LABA combination preparations

A

Symbicort (budesonide/formoterol)
seretide (fluticasone/salmeterol)
breo (fluticasone/vilanterol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

typical symptoms of asthma

A

dyspnoea
tightness
wheeze
cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

especially likely to be asthma if presenting with

A

worse at night
triggered by RTIs/exercise/cold air/allergens
relieved by bronchodilator
recurrent / seasonal
Fix asthma / personal or FHx atopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what does obstructive look like on spirometry

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what does restrictive pattern look like on spirometry

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

reversibility

A

there should be a 12% improvement in FEV1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

reproducibility of spirometry

A

less than 150ml difference in FVC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

does normal spirometry exclude asthma

A

no

22
Q

good technique for spirometry

A

seated, good seal, good effort, all the way out, no coughing (esp. in first second of test)

23
Q

severity of asthma

A

mild
moderate
severe
difficult-to-treat
severe treatment resistant asthma (severe refractory asthma)

24
Q

drug treatment that everyone requires for asthma

A

reliever for symptomatic (prn) use
this is arguably all that is needed if symptoms < twice per month and no exacerbation within the last year

25
Q

when to prescribe a preventer

A

if more severe than symptoms < twice per month and no exacerbation within the last year
usually start with lowest dose at which symptoms are controlled

26
Q

when to use a LABA

A

sometimes indicated in combination with ICS if more frequent or uncontrolled symptoms
don’t prescribe them on their own

27
Q

guidelines for treatment levels for asthma

A
28
Q

MART

A

maintenance and deliver therapy
different approach of using ICS-formoterol prn like a reliever as well as preventer
to maximum of 12 puffs total daily from dry powder inhaler

29
Q

MART is indicated in patients with

A
  • frequent asthma symptoms despite ICS or ICS/LABA
  • good at perceiving airway obstruction
  • don’t overuse SABAs
30
Q

SABA relievers

A
31
Q

LABA medications

A
32
Q

ICS preventers

A
33
Q

non-steroidal preventer

A
34
Q

ICA/LABA

A
35
Q

spacers

A

use with MDIs not with dry powder inhalers
wash plastic ones before use with dish washing detergent and drip dry (do not wipe)

36
Q

DPIs and MDIs

A

equally efficacious
DPIs may not be suitable for for young children (<6) and people with severe asthma with limited inspiratory capacity

37
Q

most patients will need

A
38
Q

some patients will need

A
39
Q

few patients will need

A
40
Q

obstructive picture

A

concave
obstruction of flow butno reestriction of volume

41
Q

restrictive picture

A
42
Q

mixed picture

A
43
Q

two SABAs

A

salbutamol and terbutaline

44
Q

inhaled corticosteroids

A

beclomethhasone, budesonide, fluticasone, ciclesonide

45
Q

three LABAs

A

formoterol, salmeterol, vilanterol

46
Q

symbiccort contains

A

formoterol and budesonide

47
Q

seretide contains

A

fluticasone and salmeterol

48
Q

SMART theraapy

A

symbicort maintenance and. reliever therapy

49
Q

6steps of asthma management

A

assess severity
achieve best lung function
maintain best lung function (identify and avoid triggers)
optimise medications
action plan
educate and rreview regularly

50
Q
A